Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due ...

Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The quarter started with tariff ...

In trading on Monday, shares of Bio-Techne Corp (Symbol: TECH) crossed above their 200 day moving average of $73.66, changing hands as high as $74.93 per share. Bio-Techne Corp shares are currently ...

We came across a bullish thesis on Bio-Techne Corporation on Valueinvestorsclub.com by rab. In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation’s share was trading at ...

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S. healthcare reforms, limiting near-term growth. Despite a solid business ...

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...

In the latest quarter, 7 analysts provided ratings for Bio-Techne (NASDAQ:TECH), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the ...

Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early signs ...

Fintel reports that on May 30, 2025, Wells Fargo initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Overweight recommendation. As of May 6, 2025, the average one-year price target for Bio-Techne ...

What's Indo US Bio-Tech Ltd share price today. Get Indo US Bio-Tech Ltd latest news on BSE/NSE stock price live updates, Indo US Bio-Tech Ltd financial results and overview, Indo US Bio-Tech Ltd stock ...